Open AccessMyeloid derived suppressor cells are reduced and T regulatory cells stabilised in patients with advanced pancreatic cancer treated with gemcitabine and intravenous omega 3
Author(s) -
John Isherwood,
Ali Arshad,
Wen Yuan Chung,
Franscois Runau,
Jill Cooke,
Cristina Pollard,
Lynne Howells,
Jenny Fishwick,
John R. Thompson,
Matthew S. Metcalfe,
William P. Steward,
Ashley R. Dennison
Publication year - 2020
Publication title -
annals of translational medicine
Language(s) - English
Resource type - Journals
eISSN - 2305-5847
pISSN - 2305-5839
DOI - 10.21037/atm.2020.02.02
Subject(s) - gemcitabine , medicine , pancreatic cancer , oncology , clinical trial , myeloid derived suppressor cell , adenocarcinoma , gastroenterology , myeloid , cancer , immune system , chemotherapy , immunology , suppressor
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom